JUN and cancer: In our study, it was demonstrated that c-Jun knockdown could potently decrease PD-L1 expression in both A549/CDDP and MCF7/ADR cells, suggesting that c-Jun might be a potential shared regulator of PD-L1 expression in these drug-resistant cancer cells (Additional file 1: Figure S2).